In order for clinicians to manage disease progression and make effective decisions about drug dosage, treatment regimens or scheduling follow up appointments, it is necessary to be able to identify both short and long-term trends in repeated biomedical measurements. However, this is complicated by the fact that these measurements are irregularly sampled and influenced by both genuine physiological changes and external factors. In their current forms, existing regression algorithms often do not fulfil all of a clinician's requirements for identifying short-term events while still being able to identify long-term trends in disease progression. Therefore, in order to balance both short term interpretability and long term flexibility, an extension to brokenstick regression models is proposed in order to make them more suitable for timate of the annual rate of change in the measurements more reliably than linear regression. The benefits of the proposed model are illustrated using estimated glomerular filtration rate as a case study for managing patients with chronic kidney disease.
Introduction
The trend of measurements of clinical interest such as blood sugar, cholesterol or kidney function can provide insight into the expected development of a patient's condition. For patients with chronic illnesses such as diabetes and chronic kidney disease (CKD), monitoring of these measurements is necessary in order to effectively manage the condition. For example, in order for clinicians to make effective decisions about drug dosage, treatment regimens or when schedule follow up appointments it is necessary to know not only the value of these indicators, but also to have an idea of both the shortand long-term trajectory they are following. However, modelling the trend of biomedical measurements over the long-term can be complicated by both practical, e.g. the irregular taking of measurements and lengthy gaps between them, and biological considerations. For example, the primary indicator of kidney function, the estimated glomerular filtration rate (eGFR), can be influenced by, amongst other things, the level of protein in the diet, changes in muscle breakdown and the level of hydration [1] . This can lead to substantive variability in a patient's eGFR measurements [2, 3] . Unfortunately, existing regression algorithms such as linear, polynomial and Gaussian pro-cess regression (GPR) [4] either can not account for these challenges or do not satisfy the key clinical requirements of providing an easily interpretable model that can elucidate short-and long-term trends.
As biomedical measurements are irregularly sampled, they pose an additional difficulty due to the prior work in time series analysis primarily focussing on regularly sampled data. Despite methods for anaysing irregular time series data directly having been employed successfully [5, 6, 7] , the most common approach is still to transform the data to enforce regularity using either interpolation techniques or regression analysis [8] . However, with biomedical time series interpolation can present its own problems due to the measurements not always being taken at random, but rather requested at specific times by clinicians, e.g. as part of routine monitoring or as follow up to treatment. On the other hand, regression imposes a number of assumptions on both the variables and their relationships. For example, linear regression assumes a linear relationships between the dependent and independent variables and independence of the residuals (no auto-correlation); assumptions which are usually violated in biomedical time series. Often linearity is violated due to an acute episode. For example, when a patient suffers an acute kidney injury (AKI) [9, 10, 11, 12 ] their eGFR will drop sharply and potentially recover a short time after (as seen in Figure 1 ). Long-term trends may therefore exhibit local fluctuations due to genuine physiological changes as well as external factors.
More flexible models such as Gaussian process regression (GPR) [14] , multivariate adaptive regression splines [15] and multivariate additive models [16] can be used instead to provide the desired flexibility. For example, produce a fixed-size vector of 50 observations (red) over the age range for which the patient has eGFR measurements [13] .
through the use of a kernel function GPR can avoid making the assumptions of linear regression. However, when there are gaps between the data, as is often the case with biomedical time series, the estimated variance of the predicted output can 'explode' [13] (Figure 2 ). However, these models are less interpretable, and therefore lose out in situations where a clinician simply needs to know whether a patient's condition is progressing or improving. In order to strike a balance between interpretability and flexibility, brokenstick regression, also known as segmented or piece-wise regression, can be used to linearly model local trends [17, 18, 19, 20] . However, in this formulation local discontinuities are introduced at the segment boundaries, resulting in a loss of smoothness and consequently in the ability to infer trends in the boundary regions. To address this we take a Bayesian approach to de- 
Methodology
Here, X is used to denote a vector and X[t] to denote the element in the vector indexed by t. The remainder of the notation used is given in Table 1 .
Windowing
The first step in fitting the broken-stick model is the division of a time 
Local Fitting
Given d and a specified interval to slide the window by, ∆ d , the number of windows W is also determined. For each window, a linear regression is performed by:
where
is the gradient and ω
is the intercept for the w-th window
The fitting of each window is summarised in Figure 3 . 
Window Influence
In order to smoothly join the fitted line segment we take a Bayesian approach. Let P (x|t) be the distribution of the repeated measurement x given the time t. The local regression models will then give P (x|w, t) for w = 1, . . . , W . These two quantities can be seen to be related by:
where P (w|t) is the posterior probability of the w-th window at time t.
Ideally the further away in time a window is from t the less influence its line segment has near t. One way to achieve this is to use Bayes' theorem to define P (w|t) such that P (w|t) ∝ p(t|w) and the window function p(t|w) is bell-shaped, e.g. is Gaussian:
where µ (w) t is the mean value, i.e. the mid-point, of the time window (see Figure 3 ):
and σ (w) is the standard deviation. This must be a function of d, not the window, as the standard deviation does not vary from one window to another.
Here, σ (w) = σ = Having defined p(t|w), we can use Bayes' theorem to obtain P (w|t):
w p(t|w )P (w ) where the prior, P (w), dictates which windows should be given more weight.
When a flat prior is used, we have:
w p(t|w ) The difference between p(t|w) and P (w|t) is depicted in Figure 4 .
Predicted Values and Confidence Intervals
Since the expected value of the final regression, for a given t, is given by for each window w = 1, . . . , 11 is plotted in a different colour. As the posterior probability has the property that w P (w|t * ) = 1, the first and last windows dominate the posterior probability near the boundaries, i.e. near L [1] and U [11] .
it follows that we can plug (2) into it:
Taking the expectation E x on both sides of the equation we obtain:
Therefore, the global mean regression function is a weighted sum of the local mean regression functions, with weights determined by P (w|t) at any given time point t. Taking approximately 95% of the probability mass, the intervals around the global mean can be defined by: and
respectively, for the lower and upper intervals. Therefore, we have µ
The local line fitting for a patient's time series can be seen in Figure 5 (a), with the final fitted curve in (b).
Computing the Rate Change
Another useful quantity that can be derived from the global model parametrically is the annual rate change of the time series. To do so, for each of the W line segments fitted using (1), we first compute its first derivative
1 . The rate change can then be computed as:
noting that due to it being a linear function, ω
does not change with the time. The global mean trend of a patient's eGFR, given by (5), and the slope, computed using (8), can be seen in Figure 6 for four randomly selected patients. Output: trend, {µ t ± σ t |t} annual rate change, {µ t |t} 2 W = length(U ) % Obtain the window length 3 % Create the window
, σ) for t ∈ T 6 end 7 % Normalize the window weight (Equation (4))
10 end 11 % Get the local trends 12 T = sample(t U , t L ,1000) %draw 1000 equall-spaced samples
µ w (t) = Calculate first derivative (θ w ), for t ∈ T 16 end 17 % Combine the local trends and the weights as in Equations (5-8) Figure 7 . From this it can be seen that shorter window lengths and shorter intervals produce more sensitive models, as can be seen in the differences between (c) and (f) and between (e), (f) and (g) in terms of the magnitude of the slope. The impact of choosing windows lengths and intervals that are too large can also be seen in the lack of local fluctuations in (g). From
this it is reasonable to conclude that the expected eGFR and slope are only comparable between patients when the same fitting parameters are used.
Case Study
In order to demonstrate the utility of the proposed broken-stick model, we applied it to primary care data collected for the QICKD study [21] in order to model the long-term trend of eGFR measurements. For patients with CKD, their eGFR is one of the primary outcomes used by clinicians and is used in determining the stage, and therefore severity, of a patient's CKD. While a true clinical staging of CKD will take kidney damage, as evidenced by the level of albuminuria, into account as well as eGFR, we focus only on eGFR
here in order to demonstrate the utility of the proposed broken-stick model.
The possible stages of CKD as a function of a patient's eGFR value can be seen in 
The QICKD Dataset
The QICKD dataset contains the primary care records of 951,764 patients. Of these records, 12,297 contain an eGFR measurement (45.4% male and 56.6% female). In total, there were 109,397 eGFR measurements across the patients, with approximately 95% between the values of 25 and 120 mL/min/1.73m 2 and occurring in patients between the ages of 60 and 103. eGFR measurement were discarded for having less than three years worth of measurements and twenty-six for having gaps between measurements of larger than three years. Ten patients were also discarded for having an overly large gradient, likely as a result of large gaps between measurements isolating individual measurements. Each patient's eGFR sequence was also labelled, using the SAKIDA algorithm [9] , with the number of acute kidney injury (AKI) episodes experienced by the patient. As an AKI represents a sudden and substantive change in the eGFR trend, and could therefore interfere with the trend modelling, the 1,103 patients identified as having experienced an AKI episode are excluded. In total 2,603 patients were excluded, leaving 9,694.
From Figure 8 (c) it can be seen that there are abrupt changes in the distribution of the measurements at both 60 and 90 mL/min/1.73m 2 . There are likely two reasons for this:
• Measurements above 60 or 90, depending on the testing laboratory, are truncated and reported as either 60 or 90 respectively. This practice results in a peak in the distribution at 60 and 90 mL/min/1.73m 2 .
• The reliability of eGFR measurements decreases as the value of the measurement increases due to the associated variance increasing with the value of the measurement. Therefore, eGFR measurements above certain values, 60 and 90, are often reported as greater than 60 or 90 but a numeric value is not recorded in the patient's record. This likely accounts for the observed drop in the distribution following 60 and 90 mL/min/1.73m 2 .
Due to the increased variance of larger eGFR measurements, any values above 120 mL/min/1.73m 2 are removed from the patient's time series and excluded from the study. 
Staging and Stratifying CKD
Accurate staging of CKD is dependent on being able to take a stable measurement of a patient's eGFR. Therefore, one of the major drawbacks of current approaches to CKD staging is the variability of eGFR measurements due to their sensitivity to natural fluctuations in the breakdown of protein, e.g. from changing levels of protein in the diet, muscle breakdown and hydration, in addition to clinical factors. It is therefore possible for the trend in a patient's eGFR to be interrupted due to benign external factors, thereby masking a more serious decline in kidney function and frustrating clinicians'
attempts to reliably determine a patient's CKD stage.
As an alternative to relying on the, potentially noisy, raw eGFR values when making staging decisions, here we use the estimated mean eGFR value obtained directly from the broken-stick model. To this end, we use a Bayesian framework to formulate the problem. Let g t be the eGFR measurement taken at time t and {g t |t ∈ T }, where T ≡ {1, . . . , T }, be an eGFR time series. Then, after applying the broken-stick model, we have the corresponding regressed mean {µ t |t ∈ T }. Using this notation, CKD stages can be determined using the following equation:
where g is a raw eGFR measurement value and [g
is the eGFR range that defines a given CKD stage l ∈ {0, 1, 2, 3, 4, 5}. The upper and lower bounds for each CKD stage are shown in Table 2 . Given that there are no available ground-truth CKD stages, and as µ is an estimated eGFR value, we can perform the staging using it, rather than g, via the following equation
20
:
In order to ascertain whether the the CKD stages determined using µ and g are consistent with one another, the distribution p(g|CKD(µ)) was calculated for each CKD stage and the following equation used to determine the posterior probability of an expected given the raw eGFR value g:
where CKD(µ) ranges from 0 to 5. In order to prevent the prior dominating the posterior, a uniform prior P (CKD(µ)) was used, resulting in the following equation:
The posterior probability distributions calculated using (11) can be seen in Figure 9 (a). It is noticeable from this that the boundaries used to determine CKD stages from raw eGFR values, according to the KDIGO guidelines [22] in Table 2 , are not consistent with with the expected stage boundaries.
In addition to using the broken-stick model to determine CKD stages, by calculating the eGFR slope using (8) it is possible to both stage and stratify patients according to the trajectory that their condition is taking.
By calculating both the expected eGFR value (µ) and slope (µ ) at a given point, and recognising that stages 1 and 2 are often considered to be mild CKD, it is possible to stratify patients into four rough categories based on their outlook:
• Good: Patients in this category have mild, or no, CKD and a positive trajectory.
• Requires monitoring: Patients in this category have more severe CKD but show a positive trajectory, and may therefore be less likely to have their CKD worsen.
• Requires close monitoring: Patients in this category are characterised by having mild CKD but a worsening outlook due to the negative eGFR slope.
• Intervention required: In this category patients have advanced and worsening CKD.
Discussion and Conclusions
The proposed broken-stick model can robustly estimate both short-term of CKD progression can be based on both short-and long-term trends, and is difficult to evaluate from raw eGFR values alone. As a demonstration of the utility of the broken-stick model for assisting in the management of CKD, it was applied to the eGFR time series contained in the electronic medical records of approximately 10,000 patients. When compared to the CKD staging following the KDIGO guidelines, the stages determined using the broken-stick model are largely consistent, with the exception of between stages 1 and 2 where eGFR measurements are less reliable. Given this consistency, the gradient-based patient stratification is likely to prove reliable as it relies on the same model. Taken together, these results could provide useful information when determining the trajectory of a patient's condition and in the retrospective identification of patients for clinical research. Additionally, given its flexibility and wide applicability, the probabilistic broken-stick model could easily be applied to the modelling of additional biomedical measurements, such as plasma glucose concentration in diabetes.
